Authors
Loading...
Analysis reveals glycan-bNAb interactions vary by HIV-1 clade, impacting therapy efficacy and design.
Arandhara et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: